SCHEMBL29792971

SCHEMBL29792971

COC1C2O[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)OC[C@H]2O[C@H]1n1cnc2c(NC(C)C)ncnc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PDE4A P27815 2/20 0.39
▸ PDE4D Q08499 2/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ ADRB3 P13945 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ DOT1L Q8TEK3 1/20 0.37
▸ PRKAG1 P54619 1/20 0.37
▸ PRKAA1 Q13131 1/20 0.37
▸ PRKAB1 Q9Y478 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29792984 0.87 PDE4A (0.44) MEN1KMT2APDE4APDE4DPDE4B
SCHEMBL1797958 0.87 PDE4A (0.44) MEN1KMT2APDE4APDE4DPDE4B
SCHEMBL1795561 0.83 UBA6 (0.48) —
SCHEMBL17363566 0.81 P2RY12 (0.34) PDE4APDE4DPDE4BPDE4CCYP1A2
SCHEMBL17363565 0.81 P2RY12 (0.34) PDE4APDE4DPDE4BPDE4CCYP1A2
SCHEMBL6938343 0.80 PDE4A (0.59) PDE4APDE4DPDE4BPDE4CRXFP1
SCHEMBL8939101 0.79 STING1 (0.38) ADORA3ADORA2A
SCHEMBL8939099 0.79 STING1 (0.38) ADORA3ADORA2A
SCHEMBL5963251 0.79 STING1 (0.38) ADORA3ADORA2A
SCHEMBL21118747 0.78 PDE4A (0.36) PDE4APDE4DPDE4BPDE4CCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4277636-A1 MODIFIED OLIGONUCLEOTIDES Alnylam Pharmaceuticals, Inc. (US) 2023-11-22 — — EP disclosed
WO-2022155418-A1 MODIFIED OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2022-07-21 — — WO disclosed
Send feedback